1. Home
  2. FHB vs IDYA Comparison

FHB vs IDYA Comparison

Compare FHB & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Hawaiian Inc.

FHB

First Hawaiian Inc.

HOLD

Current Price

$26.96

Market Cap

3.0B

Sector

Finance

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$28.05

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FHB
IDYA
Founded
1858
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.9B
IPO Year
2016
2019

Fundamental Metrics

Financial Performance
Metric
FHB
IDYA
Price
$26.96
$28.05
Analyst Decision
Sell
Strong Buy
Analyst Count
7
16
Target Price
$27.00
$52.86
AVG Volume (30 Days)
1.6M
1.6M
Earning Date
04-24-2026
05-06-2026
Dividend Yield
3.83%
N/A
EPS Growth
22.91
61.90
EPS
2.20
N/A
Revenue
$880,788,000.00
$218,710,000.00
Revenue This Year
$7.00
N/A
Revenue Next Year
$3.56
$201.05
P/E Ratio
$12.31
N/A
Revenue Growth
8.94
3024.43
52 Week Low
$22.62
$16.82
52 Week High
$28.35
$39.28

Technical Indicators

Market Signals
Indicator
FHB
IDYA
Relative Strength Index (RSI) 59.58 33.07
Support Level $25.95 $22.22
Resistance Level $27.68 $28.41
Average True Range (ATR) 0.63 1.92
MACD 0.03 -0.40
Stochastic Oscillator 54.04 0.59

Price Performance

Historical Comparison
FHB
IDYA

About FHB First Hawaiian Inc.

First Hawaiian Inc is a bank holding company. It provides a diversified range of banking services to consumer and commercial customers, including deposit products, lending services, and wealth management and trust services. The company offers a variety of deposit products to its customers, including checking and savings accounts and other types of deposit accounts. It provides commercial and industrial lending, including auto dealer flooring, commercial real estate, and construction lending. It also offers comprehensive consumer lending services focused on residential real estate lending, indirect auto financing, and other consumer loans. The company's segments are Retail Banking, Commercial Banking, and Treasury, and others of which key revenue is derived from Retail Banking.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: